Target：REEP1
Gene Name：REEP1 C2orf23
Protein Name：Receptor expression-enhancing protein 1
Human Gene Id：65055
Human Swiss Prot No：Q9H902
Mouse Swiss Prot No：Q8BGH4
Immunogen：Synthesized peptide derived from human protein . at AA range: 61-110
Specificity：REEP1 Polyclonal Antibody detects endogenous levels of protein.
Formulation：Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
Source：Polyclonal, Rabbit,IgG
Dilution：WB 1:500-2000 ELISA 1:5000-20000
Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration：1 mg/ml
Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)
Observed Band(KD)：22kD
Background： This gene encodes a mitochondrial protein that functions to enhance the cell surface expression of odorant receptors. Mutations in this gene cause spastic paraplegia autosomal dominant type 31, a neurodegenerative disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009],
Function：disease:Defects in REEP1 are the cause of spastic paraplegia autosomal dominant type 31 (SPG31) [MIM:610250]. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.,function:May enhance the cell surface expression of odorant receptors.,similarity:Belongs to the DP1 family.,subunit:Interacts with odorant receptor proteins.,
Subcellular Location：Membrane . Mitochondrion membrane ; Multi-pass membrane protein . Endoplasmic reticulum . Localizes to endoplasmic reticulum tubular network. .
Expression：Expressed in circumvallate papillae and testis.
